COMP <GO>
KEQU vs SERA // EV/EBITDA & P/E VALUATION
Kewaunee Scientific Corporation (NASDAQ) VS. Sera Prognostics Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: KEQU 8
— SERA 1
■ METRIC PARITY
LAST: $33.51 (-3.48%) • MKT CAP: $97.0M
valuation
6.3x
LAST: $2.06 (+1.48%) • MKT CAP: $81.3M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KEQU VS. SERA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KEQU | SERA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.50% | -30.00% | +58.50 | KEQU | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.70% | -35.00% | +51.70 | KEQU | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 6.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 19.20% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 5.90% | -60.00% | +65.90 | KEQU | /operating-margins <GO> |
| Net Profit Margin | 3.40% | -60.00% | +63.40 | KEQU | /net-margins <GO> |
| Revenue Growth (YoY) | 17.30% | 5.20% | +12.10 | KEQU | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.37 | 0.20 | +3.17 | KEQU | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | KEQU | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.8 | 49.4 | -13.55 | SERA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 8.5x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $97.0M | $81.3M | $15.8M | KEQU | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KEQU REV | SERA REV | KEQU GROSS % | SERA GROSS % | KEQU FCF | SERA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $282.0M | $81.0K | 28.5% | -50.0% | $18.6M | -$26.3M |
| FY 2024 | $240.5M | $77.0K | 28.6% | -6.5% | $14.8M | -$14.2M |
| FY 2023 | $203.8M | $306.0K | — | — | $19.6M | -$27.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KEQU // BETA —
SERA // BETA —